Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Pennsylvania
With
National Institutes of Health (NIH)
Harvard Vanguard Medical Associates
Geisinger Clinic
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Between the ages of 18-80 yrs
FRS of \> 20% with LDL \> 120, or FRS = 10-20% with LDL \> 140, or a coronary artery disease equivalent (diabetes, peripheral artery disease, ischemic CVD, arteriosclerotic CVD, stroke/TIA, CABG, coronary stenting, or coronary bypass anastomosis) with LDL \> 120.
You may not be if
Patients with a history of side effects to statins. Patients with a history of side effects to statins will be forwarded to the study's medical monitor (a physician aligned with the study) and may still participate in the study if, after the medical monitor reviews the patient's medical record, he/she determines that the patient may safely participate in the study;
Patients who will not or cannot give consent;
Patients with terminal illness who are no longer suitable candidates for aggressive lipid management as determined by the patient's primary care physician;
Patients with ALT values detected at greater than 80 U/L;
Patients with active or progressive liver disease.
Clareo Health | A Randomized Trial of Patient Financial Incentives to Reduce CVD Risk
